Airis Pharma has announced a recruitment opportunity for the position of Senior Executive – Formulation Research & Development (R&D) in Hyderabad, Telangana. The company is looking for experienced pharmaceutical professionals with expertise in sterile injectable formulations, ophthalmic products, and lyophilization.
This opportunity is suitable for candidates with an M.Pharm in Pharmaceutics and 3–5 years of relevant experience in pharmaceutical formulation development. Selected candidates will have the opportunity to work on specialized pharmaceutical products, product development activities, technology transfer, and scale-up operations.
Airis Pharma Recruitment 2026 – Job Overview
Company Name: Airis Pharma
Job Position: Senior Executive – Formulation R&D
Department: Formulation Research & Development
Specialization: Parenteral / Ophthalmic
Job Location: Hyderabad, Telangana
Qualification: M.Pharm (Pharmaceutics)
Experience Required: 3–5 years
Industry: Pharmaceutical
Recruitment Type: Experienced professional hiring
Application Mode: Contact via email or LinkedIn
Educational Qualification and Experience
Candidates must possess an M.Pharm degree in Pharmaceutics and have approximately 3–5 years of relevant experience in pharmaceutical formulation research and development.
Applicants should have practical experience in sterile injectable or ophthalmic dosage-form development. Knowledge of lyophilization, sterile manufacturing processes, formulation optimization, stability studies, and technology transfer will be important for this position.
Experience with complex parenteral formulations will be an added advantage.
Job Responsibilities
The selected candidate will be responsible for the following activities:
Formulation and Process Development: Conduct formulation research and process development activities for parenteral pharmaceutical products.
Preformulation Studies: Perform compatibility studies, stability evaluations, formulation optimization, and related investigations.
Lyophilization Development: Develop and optimize freeze-drying cycles and establish scalable manufacturing processes for lyophilized products.
Sterile Product Development: Support the development of sterile injectable and ophthalmic formulations.
Scale-Up Activities: Assist with exhibit batches, process scale-up, and preparation for commercial manufacturing.
Technology Transfer: Support the transfer of formulation and process knowledge from R&D to manufacturing.
Documentation: Prepare development reports, Standard Operating Procedures (SOPs), Master Formula Records (MFRs), stability documentation, and regulatory support documents.
Cross-Functional Coordination: Collaborate with Analytical Development, Quality Assurance (QA), Regulatory Affairs, and Manufacturing teams.
Scientific Problem-Solving: Investigate formulation and process-related challenges and support continuous improvement.
Required Technical Skills and Expertise
Candidates should have knowledge and practical experience in the following areas:
Sterile injectable and ophthalmic dosage-form development
Lyophilization and freeze-drying cycle optimization
Sterile injection formulation and manufacturing processes
Technology transfer and manufacturing scale-up
ICH stability requirements and stability study interpretation
Quality by Design (QbD) principles
Pharmaceutical formulation optimization and compatibility studies
Global regulatory expectations for pharmaceutical products
Technical documentation, analytical interpretation, and communication
A strong understanding of sterile product development and pharmaceutical quality requirements will be beneficial for this role.
Why Join Airis Pharma?
This opportunity offers experienced pharmaceutical professionals the chance to work in specialized formulation development and contribute to the development and commercialization of pharmaceutical products.
Potential professional benefits include:
Exposure to niche pharmaceutical products and complex formulations.
Experience with global regulatory expectations.
Involvement in product development from research through commercialization.
Opportunities to work with cross-functional pharmaceutical teams.
A collaborative and innovation-focused R&D environment.
How to Apply for Airis Pharma Recruitment 2026
Interested and eligible candidates can contact the recruitment representative through the details provided in the recruitment advertisement.
Contact Person: CG Ravi
Email: ravicg@airispharma.com
LinkedIn: CG Ravi – Verified Profile
Candidates should send an updated CV highlighting their experience in sterile injectable or ophthalmic formulation development, lyophilization, technology transfer, and scale-up activities.
Important: The advertisement does not specify a last date for application or salary details. Candidates should confirm the latest vacancy status and any additional recruitment requirements before applying.
Frequently Asked Questions (FAQs)
1. What is the qualification required for the Senior Executive – Formulation R&D position at Airis Pharma?
Candidates should have an M.Pharm degree in Pharmaceutics. Approximately 3–5 years of relevant experience in pharmaceutical formulation R&D is required.
2. What technical knowledge is important for this pharmaceutical R&D job?
Candidates should have experience in sterile injectable and ophthalmic formulation development, preformulation studies, compatibility testing, formulation optimization, lyophilization, and stability studies. Knowledge of technology transfer, scale-up, and QbD principles is also important.
3. What is lyophilization, and why is it important in injectable formulation development?
Lyophilization, also known as freeze-drying, is a process in which a product is frozen and water is removed by sublimation under reduced pressure, followed by secondary drying. It is used to improve the stability of suitable drug products that are sensitive to moisture or have limited stability in aqueous solutions. Development requires appropriate cycle optimization and product-specific validation.
4. What are the key technical considerations in sterile injectable and ophthalmic formulation development?
Important considerations include formulation compatibility, solubility, pH, stability, sterility assurance, particulate control, container-closure compatibility, and appropriate manufacturing controls. Ophthalmic products may also require evaluation of parameters such as osmolality, viscosity, and ocular tolerability, depending on the formulation. Applicable pharmacopeial and regulatory requirements must be followed.
5. What are technology transfer, scale-up, ICH stability, and QbD in pharmaceutical R&D?
Technology transfer involves transferring product and process knowledge from development to manufacturing. Scale-up evaluates whether the process can be reproduced reliably at larger batch sizes. ICH stability studies assess how product quality changes under specified storage conditions. Quality by Design (QbD) is a systematic approach to pharmaceutical development that identifies critical quality attributes, critical process parameters, and associated risks to help ensure consistent product quality.
Conclusion: Airis Pharma’s Senior Executive – Formulation R&D recruitment is an opportunity for experienced M.Pharm professionals seeking to advance their careers in sterile injectable, ophthalmic, and lyophilized pharmaceutical product development. Eligible candidates with relevant technical expertise can share their updated CV using the contact details provided in the recruitment advertisement.
Airis Pharma Recruitment: Senior Executive – Formulation R&D (Parenteral/Ophthalmic) in Hyderabad
The post Airis Pharma Recruitment: Senior Executive – Formulation R&D (Parenteral/Ophthalmic) in Hyderabad appeared first on The Jobs Post –Job Alerts for Freshers & Experts.
